Global Myofascial Treatment With Shockwave for Non-Specific Low Back Pain
NCT: NCT07692347 · COMPLETED
Brief Summary
This study aims to examine the effects of shockwave therapy on myofascial tissue (muscles, fascia, and connective tissue), focusing on pain reduction and improvement of mobility. The results will be compared with those of conventional manual physiotherapy. Myofascial tissue can be a source of back pain, as it may contain painful spots known as myofascial trigger points (MTrPs). Shockwave therapy can stimulate these trigger points, potentially leading to muscle and fascia relaxation and, as a result, a decrease in pain. The study investigates how focused shockwave trigger point therapy influences back function and pain perception compared to traditional physiotherapeutic treatment. Participation is voluntary. The examinations will only be carried out if you provide written informed consent. You may refuse participation or withdraw your consent at any time without any disadvantages.
Frequently Asked Questions
What is Global Myofascial Treatment With Shockwave for Non-Specific Low Back Pain?
Global Myofascial Treatment With Shockwave for Non-Specific Low Back Pain is a clinical trial registered under NCT07692347. Current status: COMPLETED.
What is the status of NCT07692347?
The current status of NCT07692347 (Global Myofascial Treatment With Shockwave for Non-Specific Low Back Pain) is: COMPLETED.
When did Global Myofascial Treatment With Shockwave for Non-Specific Low Back Pain start?
Global Myofascial Treatment With Shockwave for Non-Specific Low Back Pain started on 2022-08-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.